The absence of HIF-1α increases susceptibility to Leishmania donovani infection via activation of BNIP3/mTOR/SREBP-1c axis I Mesquita, C Ferreira, D Moreira, GEG Kluck, AM Barbosa, E Torrado, ... Cell Reports 30 (12), 4052-4064. e7, 2020 | 39 | 2020 |
Pro-inflammatory cytokine Interleukin-1β (IL-1β) controls Leishmania infection T Patil, V More, D Rane, A Mukherjee, R Suresh, A Patidar, N Bodhale, ... Cytokine 112, 27-31, 2018 | 21 | 2018 |
Cytokines and metabolic regulation: A framework of bidirectional influences affecting Leishmania infection N Bodhale, M Ohms, C Ferreira, I Mesquita, A Mukherjee, S Andre, ... Cytokine 147, 155267, 2021 | 18 | 2021 |
Leishmania intercepts IFN-γR signaling at multiple levels in macrophages D Gurjar, SK Patra, N Bodhale, N Lenka, B Saha Cytokine 157, 155956, 2022 | 14 | 2022 |
The expression of PD-1 and its ligands increases in Leishmania infection and its blockade reduces the parasite burden A Jafarzadeh, S Kumar, N Bodhale, S Jafarzadeh, M Nemati, I Sharifi, ... Cytokine 153, 155839, 2022 | 12 | 2022 |
Development and characterization of an avirulent Leishmania major strain MK Jha, AY Sarode, N Bodhale, D Mukherjee, SP Pandey, N Srivastava, ... The Journal of Immunology 204 (10), 2734-2753, 2020 | 12 | 2020 |
Inbred mouse strains differentially susceptible to Leishmania donovani infection differ in their immune cell metabolism NP Bodhale, S Pal, S Kumar, D Chattopadhyay, B Saha, ... Cytokine 112, 12-15, 2018 | 11 | 2018 |
Interdependencies between Toll‐like receptors in Leishmania infection D Shukla, A Patidar, U Sarma, P Chauhan, SP Pandey, HS Chandel, ... Immunology 164 (1), 173-189, 2021 | 10 | 2021 |
Neutrophils: Interplay between host defense, cellular metabolism and intracellular infection R Deepti, P Tejaswini, M Vasundhara, P Sushree Sangita, B Neelam, ... Cytokine 112, 44-51, 2018 | 9 | 2018 |
Bidirectional cytokine-microRNA control: A novel immunoregulatory framework in leishmaniasis A Jafarzadeh, M Nemati, N Aminizadeh, N Bodhale, A Sarkar, ... PLoS Pathogens 18 (8), e1010696, 2022 | 8 | 2022 |
The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression B Saha, K Pai, S Sundar, M Bhattacharyya, NP Bodhale Cytokine 145, 155300, 2021 | 8 | 2021 |
TLR2 dimer‐specific ligands selectively activate protein kinase C isoforms in Leishmania infection A Mukherjee, S Roy, A Patidar, N Bodhale, J Dandapat, B Saha, A Sarkar Immunology 164 (2), 318-331, 2021 | 7 | 2021 |
Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani S Kumar, N Bodhale, SK Patra, A Sarode, L Zhao, A Sarkar, B Saha Cytokine 174, 156475, 2024 | 4 | 2024 |
LmjMAPK10 offers protection against Leishmania donovani infection S Kumar, S Zutshi, A Patidar, N Bodhale, S Roy, A Sarkar, B Saha Parasite Immunology 42 (2), e12687, 2020 | 4 | 2020 |
Conundrums in leishmaniasis B Saha, S Bhattacharjee, A Sarkar, R Bhor, K Pai, N Bodhale Cytokine 145, 155304, 2021 | 3 | 2021 |
SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection BP Chowdhury, S Das, N Bodhale, SP Pandey, R Sudan, N Srivastava, ... Cytokine 171, 156373, 2023 | 2 | 2023 |
Toll-like receptor 2 selectively modulates Ras isoforms expression in Leishmania major infection A Srivastava, A Nair, SP Pandey, GEG Kluck, I Mesquita, T Ghosh, A Bose, ... Cytokine 169, 156301, 2023 | 2 | 2023 |
Aberrant expression of SOCS impairs the anti-leishmanial immune response A Jafarzadeh, D Gurjar, N Bodhale, S Jafarzadeh, M Nemati, I Sharifi, ... Cytokine 174, 156461, 2024 | 1 | 2024 |
Leishmania surface molecule lipophosphoglycan‐TLR2 interaction moderates TPL2‐mediated TLR2 signalling for parasite survival SK Ghosh, D Shukla, H Mahor, SK Srivastava, N Bodhale, R Banerjee, ... Immunology 171 (1), 117-130, 2024 | 1 | 2024 |
TLR2, TLR3, TLR4, TLR9 and TLR11 expression on effector CD4+ T-cell subsets in Leishmania donovani infection A Patidar, D Shukla, N Bodhale, B Saha Experimental Parasitology 255, 108645, 2023 | 1 | 2023 |